全文获取类型
收费全文 | 2625篇 |
免费 | 125篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 151篇 |
妇产科学 | 115篇 |
基础医学 | 316篇 |
口腔科学 | 99篇 |
临床医学 | 300篇 |
内科学 | 482篇 |
皮肤病学 | 35篇 |
神经病学 | 236篇 |
特种医学 | 37篇 |
外科学 | 216篇 |
综合类 | 8篇 |
预防医学 | 291篇 |
眼科学 | 49篇 |
药学 | 212篇 |
中国医学 | 3篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 12篇 |
2022年 | 16篇 |
2021年 | 30篇 |
2020年 | 26篇 |
2019年 | 46篇 |
2018年 | 49篇 |
2017年 | 33篇 |
2016年 | 55篇 |
2015年 | 67篇 |
2014年 | 82篇 |
2013年 | 131篇 |
2012年 | 171篇 |
2011年 | 169篇 |
2010年 | 109篇 |
2009年 | 102篇 |
2008年 | 166篇 |
2007年 | 198篇 |
2006年 | 181篇 |
2005年 | 169篇 |
2004年 | 142篇 |
2003年 | 157篇 |
2002年 | 130篇 |
2001年 | 24篇 |
2000年 | 25篇 |
1999年 | 34篇 |
1998年 | 30篇 |
1997年 | 30篇 |
1996年 | 35篇 |
1995年 | 27篇 |
1994年 | 25篇 |
1993年 | 25篇 |
1992年 | 17篇 |
1991年 | 23篇 |
1990年 | 15篇 |
1989年 | 18篇 |
1988年 | 14篇 |
1987年 | 13篇 |
1986年 | 12篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 10篇 |
1981年 | 16篇 |
1980年 | 11篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1975年 | 7篇 |
1974年 | 6篇 |
1972年 | 6篇 |
1967年 | 6篇 |
排序方式: 共有2754条查询结果,搜索用时 15 毫秒
21.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - In den vergangenen 3 Jahrzehnten nahm die Qualitätsentwicklung in der Primärprävention und... 相似文献
22.
High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma 总被引:2,自引:0,他引:2
Puhakka A Kinnula V Näpänkangas U Säily M Koistinen P Pääkkö P Soini Y 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2003,111(12):1137-1146
Immunohistochemical expression of neuronal (n), endothelial (e), and inducible (i) NOS and their association with the type, grade, apoptotic index, proliferation of tumors and the survival of patients were investigated in 89 biopsies of non-small cell lung carcinoma (NSCLC). In tumor cells, expression of iNOS was detected in 35/89 (40%) cases, while 79/89 (89%) and 72/89 (81%) cases showed weak to intense positivity for eNOS and nNOS, respectively. Strong eNOS staining was seen significantly more often in adenocarcinomas than in squamous cells carcinomas (p=0.016), and iNOS immunoreactivity was seen more often in grade I-II tumors than in grade III tumors (p=0.024). There was no significant difference between the low and high apoptotic indexes or between the low and high proliferation rates of tumors in any instance of NOS staining. The patients with tumors showing high nNOS expression tended to have better survival than the others (p=0.06, log-rank; p=0.04, Bresow; p=0.048, Tarone-Ware). Similarly, the patients with tumors showing high expression of iNOS, eNOS and nNOS, as determined by a combined sum index, had a better survival than those with a low sum index for these enzymes (p<0.05). The results show intense expression of eNOS and nNOS, and moderate expression of iNOS in tumor cells of non-small cell carcinoma. Intense NOSs expression seems to be a favorable prognostic sign in non-small cell lung carcinoma. 相似文献
23.
High-dose thiotepa with autologous bone marrow rescue is a new and promising treatment modality in several kinds of solid tumors. We used this regimen in a pediatric patient who had the third recurrence of his malignant oligodendroglioma of brain that developed during 8 in 1 chemotherapy. We achieved complete response after a total dose of 1125 mg/m2 of intravenous thiotepa. Good penetration into the CNS renders thiotepa potentially useful for chemosensitive brain tumors, and one course of high-dose thiotepa can be administered with acceptable toxicity by utilizing autologous bone marrow rescue. 相似文献
24.
25.
Michael Stöckle Stefan Wellek Walter Meyenburg Gunther E. Voges Ulla Fischer Ulrich Gertenbach joachim W. Thüroff Christoph Huber Rudolf Hohenfellner 《Urology》1996,48(6):868-875
Objectives
To analyze the effectiveness of adjuvant polychemotherapy after radical cystectomy for nonorgan-confined transitional cell bladder cancer (Stages pT3b, pT4a, and/or pN1 or pN2).Methods
Of 166 consecutive patients undergoing cystectomy at two institutions from 1987 to 1993, 80 received adjuvant polychemotherapy with methotrexate, vinblastine, and cisplatin plus doxorubicin (MVAC) or epirubicin (MVEC), whereas 86 had cystectomy only. The patients were evaluated for relapse-free survival and length of progression-free interval on the basis of follow-up data obtained in 1995 and 1996.Results
Kaplan-Meier analysis revealed a significantly higher progression-free rate for patients after adjuvant chemotherapy (P=0.0002, log-rank test). With and without adjuvant chemotherapy, prognosis declined in a stepwise manner, depending on the extent of lymph node involvement. Nevertheless, the superior prognosis of the chemotherapy group could be demonstrated at each lymph node stage. Of the 166 patients, 49 had initially entered a prospective trial comparing adjuvant with no adjuvant treatment. That study was discontinued in December 1990 after an interim analysis revealed a significant prognostic advantage in favor of the 26 patients randomized to receive chemotherapy compared with the 23 control patients. Current follow-up data continue to demonstrate a significant improvement in progression-free survival in favor of patients randomized to receive adjuvant chemotherapy (P=0.0040). The follow-up period of patients living free of disease ranges from 58 to 96 months.Conclusions
Adjuvant chemotherapy with MVAC/MVEC leads to significant prolongation of relapse-free survival and improvement of the definitive cure rate after radical cystectomy for locally advanced transitional cell carcinoma of the urinary bladder. 相似文献26.
Background: Pouch volume appears to be of major importance for subsequent weight loss following any gastric restriction type
of surgery for morbid obesity. In order to be able to evaluate pouch volume following Swedish Adjustable Gastric Banding (SAGB),
an endoscopic pouch volume classification system was designed in which pouch volume is classified in five categories. The
aim of this study was to validate the endoscopic classification system using MRI and barium swallow as reference methods for
pouch volume measurement. Methods: Twenty patients (13 women and seven men) were operated for obesity with SAGB. They were
investigated a mean of 3 years (6 weeks-5.5 years) after surgery and had at that time lost a mean of 60 (12-112) kg. During
the same afternoon they sequentially underwent endoscopy, MRI and barium swallow with an empty stomach. Results: The mean
pouch volume measured with MRI was 70 ml (0-180 ml) and with barium swallow was 72 ml (0-195 ml). In 17/20 patients the volume
as measured by MRI and barium swallow was in the same volume category as with endoscopy. The correlation measured according
to Pearson was significant between endoscopy on one hand and MRI/barium swallow both independently and together (p < 0.001). Conclusion: Based on these results we are confident in using our endoscopic classification system for postoperative
follow-up of pouch volume. 相似文献
27.
Elisabet Lindholm Peter Daneryd Ulla K?rner Anders Hyltander Marita Fouladiun Kent Lundholm 《Clinical cancer research》2004,10(20):6855-6864
PURPOSE: The purpose is to evaluate relationships between objectively assessed exercise capacity and subjectively assessed scoring of physical functioning and well-being after erythropoietin treatment in cancer patients on palliative care. EXPERIMENTAL DESIGN: Unselected cancer patients (n = 108) who experienced progressive cachexia were randomized to receive either anti-inflammatory treatment alone (indomethacin) or recombinant erythropoietin plus indomethacin to prevent the appearance of disease-induced anemia and thereby protect patients' exercise capacity. Follow-up investigations of nutritional status, exercise capacity, and health-related quality of life assessed by SF-36 and the European Organization for Research and Treatment of Cancer QLQ-C30 were compared. RESULTS: Effective treatment by erythropoietin on top of basal whole body anti-inflammatory treatment was confirmed and indicated by time course changes of biochemical, physiologic, and nutritional objectives, whereas individual self-reported scoring of physical functioning and general health did not indicate a clear-cut effectiveness, particularly at moderately subnormal hemoglobin levels. CONCLUSIONS: Discrepancies between objective and subjective self-reported measures may be either fundamental or indicate scoring limitations for evaluation of therapeutic results. Present results demonstrate a clinical benefit of erythropoietin treatment in cancer patients with subnormal to normal hemoglobin levels, whereas the patients' own subjective scoring was insufficient to sense such improvements. The discrepancy may be either fundamental or methodological but emphasizes the importance to document therapeutic outcome in both subjective and objective perspectives in palliative care of cancer patients. 相似文献
28.
29.
The purpose of this study was to determine changes in nasal respiratory pattern with growth and development, particularly to determine the age where upper airway growth ceases. The results on 361 healthy subjects, aged 7 to 24 years, based on aerodynamic measurements during rest breathing, showed clear differences between inspiratory and expiratory phases. Nasal airflow rate and cross-sectional area increased and oral-nasal pressure and nasal resistance decreased with age up to the age of 16, levelling by the age of 20 years. The body size and gender had effect only on nasal airflow rate. This study suggests that the measurements of the nasal respiratory pattern, determining impaired nasal airway, should be done during inspiration and using age-related assesment from a healthy population until the age of 16 years. From then on, guidelines for adults are applicable. 相似文献
30.